Amgen Inc (AMGN) Dividend History

Amgen Inc. is a global biopharmaceutical company focused on developing and manufacturing innovative medicines in areas such as oncology, nephrology, and inflammation. Founded in 1980, Amgen is known for its work in biologic therapies and has a strong portfolio of blockbuster drugs aimed at improving patient lives.

One Amgen Center Drive, Thousand Oaks, CA, 91320
Phone: (805)447-1000
Website: https://www.amgen.com

Dividend Yield: 3.10%

Dividend Frequency: Quarterly

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
June 06, 2025	$2.38	05/16/2025	05/16/2025
March 07, 2025	$2.38	02/14/2025	02/14/2025
December 09, 2024	$2.25	11/18/2024	11/18/2024
September 06, 2024	$2.25	08/16/2024	08/16/2024
June 07, 2024	$2.25	05/16/2024	05/17/2024
March 07, 2024	$2.25	02/15/2024	02/16/2024
December 08, 2023	$2.13	11/16/2023	11/17/2023
September 08, 2023	$2.13	08/17/2023	08/18/2023
June 08, 2023	$2.13	05/17/2023	05/18/2023
March 08, 2023	$2.13	02/14/2023	02/15/2023
December 08, 2022	$1.94	11/16/2022	11/17/2022
September 08, 2022	$1.94	08/17/2022	08/18/2022
June 08, 2022	$1.94	05/16/2022	05/17/2022
March 08, 2022	$1.94	02/14/2022	02/15/2022
December 08, 2021	$1.76	11/15/2021	11/16/2021
September 08, 2021	$1.76	08/16/2021	08/17/2021
June 08, 2021	$1.76	05/14/2021	05/17/2021
March 08, 2021	$1.76	02/11/2021	02/15/2021
December 08, 2020	$1.60	11/13/2020	11/16/2020
September 08, 2020	$1.60	08/14/2020	08/17/2020
June 08, 2020	$1.60	05/15/2020	05/18/2020
March 06, 2020	$1.60	02/13/2020	02/14/2020
December 06, 2019	$1.45	11/14/2019	11/15/2019
September 06, 2019	$1.45	08/14/2019	08/15/2019
June 07, 2019	$1.45	05/16/2019	05/17/2019
March 08, 2019	$1.45	02/14/2019	02/15/2019
December 07, 2018	$1.32	11/15/2018	11/16/2018
September 07, 2018	$1.32	08/16/2018	08/17/2018
June 08, 2018	$1.32	05/16/2018	05/17/2018
March 08, 2018	$1.32	02/14/2018	02/15/2018
December 08, 2017	$1.15	11/16/2017	11/17/2017
September 08, 2017	$1.15	08/15/2017	08/17/2017
June 08, 2017	$1.15	05/15/2017	05/17/2017
March 08, 2017	$1.15	02/13/2017	02/15/2017
December 08, 2016	$1.00	11/14/2016	11/16/2016
September 08, 2016	$1.00	08/15/2016	08/17/2016
June 08, 2016	$1.00	05/13/2016	05/17/2016
March 08, 2016	$1.00	02/11/2016	02/16/2016
December 07, 2015	$0.79	11/12/2015	11/16/2015
September 08, 2015	$0.79	08/13/2015	08/17/2015
June 05, 2015	$0.79	05/12/2015	05/14/2015
March 06, 2015	$0.79	02/10/2015	02/12/2015
December 05, 2014	$0.61	11/10/2014	11/13/2014
September 05, 2014	$0.61	08/12/2014	08/14/2014
June 06, 2014	$0.61	05/13/2014	05/15/2014
March 07, 2014	$0.61	02/11/2014	02/13/2014
December 06, 2013	$0.47	11/12/2013	11/14/2013
September 06, 2013	$0.47	08/14/2013	08/16/2013
June 07, 2013	$0.47	05/14/2013	05/16/2013
March 07, 2013	$0.47	02/11/2013	02/13/2013
December 07, 2012	$0.36	11/13/2012	11/15/2012
September 07, 2012	$0.36	08/14/2012	08/16/2012
June 07, 2012	$0.36	05/14/2012	05/16/2012
March 07, 2012	$0.36	02/13/2012	02/15/2012
December 08, 2011	$0.28	11/15/2011	11/17/2011
September 08, 2011	$0.28	08/16/2011	08/18/2011

Dividends Summary

Amgen Inc has issued 56 dividend payments over the past 14 years
The most recent dividend was paid 29 days ago, on June 6, 2025
The first recorded dividend was paid on September 8, 2011
The highest dividend payout was $2.38 per share
The average dividend over this 14 year span is $1.30 per share
Amgen Inc has increased its dividend payments by 750.00% since 2011

Company News

Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity

Viking Therapeutics is developing VK2735, an oral GLP-1/GIP receptor agonist for obesity treatment with unprecedented tolerability. Early phase 2 results show 14.7% weight loss and a unique 13% discontinuation rate matching placebo, potentially revolutionizing obesity drug market.

The Motley Fool

Featured Companies: LLY PFE VKTX
Will Defensive Sectors Keep Driving Dow’s Outperformance This Summer?

The Dow Jones Industrial Average is outperforming other indices due to a shift towards defensive sectors, driven by economic uncertainty and potential Federal Reserve rate cuts. Healthcare and pharmaceutical stocks are leading the gains.

Investing.com
Analyst Views Mixed As Amgen's Weight Loss/Diabetes Drug MariTide Shows Promise But Has Dose Issues

Amgen's weight loss and diabetes drug MariTide showed promising results in a Phase 2 study, leading to significant weight loss and improvements in cardiometabolic measures. However, an analyst raised questions about the optimal dosing strategy and potential for increased gastrointestinal adverse events with longer dosing intervals.

Benzinga
Galapagos benoemt Aaron Cox als Chief Financial Officer

Galapagos has appointed Aaron Cox, former CFO of Horizon Therapeutics, as its new Chief Financial Officer. Cox brings extensive experience in biotechnology, capital markets, and mergers and acquisitions. He will play a key role in accelerating Galapagos' pipeline growth and value creation.

GlobeNewswire Inc.

Page data last updated 07/04/2025 17:25:05 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included

Amgen Inc (AMGN) Dividend History

Dividend History

Dividends Summary

Company News

Related Companies